Objective: The aim of the present study was to investigate the antimicrobial susceptibility profiles of Yersinia species, especially Y. enterocolitica from non-clinical and clinical isolates in Iran. Materials and Methods: We systematically searched PubMed, Scopus, Google Scholar, and the Scientific Information Database (SID) using “ antibiotic resistance” , “ Yersinia” , and “ Iran” as major keywords until June 10, 2019. According to the predefined article selection criteria, published studies addressing the epidemiology of antibiotic-resistant Yersinia species in Iran were included in the meta-analysis. Data were extracted and exported to the Comprehensive Meta-Analysis Software to evaluate antibiotic resistance rates, heterogeneity of studies and publication bias. Results: Twelve studies reported antimicrobial susceptibility testing using disk diffusion method. The pooled prevalence of antibiotic-resistant Yersinia species in food and clinical specimens in Iran was as follows: 22. 4% to amoxicillin, 41. 9% to ampicillin, 6% to gentamicin, 17% to trimethoprim/sulfamethoxazole, 19% to tetracycline, 10. 3% to ciprofloxacin, 10. 5% to streptomycin, 3. 8% to chloramphenicol, 79. 3% to cephalothin, 18. 4% to nalidixic acid, 6. 6% to cefotaxime, and 12. 2% to trimethoprim. Conclusion: This study revealed a high prevalence of resistant Y. enterocolitica strains isolated from food and clinical specimens in Iran to β-lactams, while the resistance rates to aminoglycosides, fluoroquinolone and chloramphenicol were low. Our findings recommended the necessity of a continuous surveillance of the resistance patterns and prudent use of trimethoprim/sulfamethoxazole, tetracycline, and nalidixic acid to prevent the development of antibiotic-resistant Y. enterocolitica strains in Iran.